Skip links

Author: oncologs.com

new-drug-prevents-flu-related-inflammation-and-lung-damage

New drug prevents flu-related inflammation and lung damage

(MEMPHIS, Tenn. – April 10, 2024) Infection with the influenza virus leads to lung injury through inflammation over-activation that causes collateral damage to cells required for breathing. Such damage can be life-threatening, but scientists have a new preventative treatment. A team from St. Jude Children’s
ai-assisted-breast-cancer-screening-may-reduce-unnecessary-testing

AI-assisted breast-cancer screening may reduce unnecessary testing

Using artificial intelligence (AI) to supplement radiologists’ evaluations of mammograms may improve breast-cancer screening by reducing false positives without missing cases of cancer, according to a study by researchers at Washington University School of Medicine in St. Louis and Whiterabbit.ai, a Silicon Valley-based technology startup.
a-new-coating-method-in-mrna-engineering-points-the-way-to-advanced-therapies

A new coating method in mRNA engineering points the way to advanced therapies

Researchers from Tokyo Medical and Dental University (TMDU) have developed a novel method for chemically modifying engineered messenger RNA molecules, allowing greater control of their biological functions and advancing mRNA therapeutic technologies Credit: Department of Advanced Nanomedical Engineering, TMDU Researchers from Tokyo Medical and Dental
a-promising-target-for-new-rna-therapeutics-now-accessible

A promising target for new RNA therapeutics now accessible

RNA has long been considered only as a passive messenger in the cell, produced by DNA transcription to transfer genetic information to the protein factories, the ribosomes. However, it has turned out, that RNA does much more than that. In addition to the coding DNA
periostin-shows-promise-to-help-fight-a-common-form-of-esophageal-cancer

Periostin shows promise to help fight a common form of esophageal cancer

Philadelphia, April 9, 2024 – Esophageal squamous cell carcinoma (ESCC) accounts for around 90% of esophageal cancers, especially in East Asia. New findings in The American Journal of Pathology, published by Elsevier, indicate that periostin, or POSTN, promotes ESCC progression by enhancing cancer and stromal
Explore
Drag